Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma

Journal of Human Hypertension

Volumn 25, Issue 2, 2011, Pages 114-121

  Morimoto, R ^a   Kudo, M ^a   Murakami, O ^a   Takase, K ^a   Ishidoya, S ^a   Nakamura, Y ^a   Ishibashi, T ^a   Takahashi, S ^a   Arai, Y ^a   Suzuki, T ^a   Sasano, H ^a   Ito, S ^a   Satoh, F ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

adrenal venous sampling; aldosterone producing microadenoma; cortisol producing adrenal adenoma; Cushing syndrome; endocrine hypertension

Indexed keywords

ALDOSTERONE; AZELNIDIPINE; BENIDIPINE; BUNAZOSIN; CAPTOPRIL; CARVEDILOL; CORTICOTROPIN; DEXAMETHASONE; DOXAZOSIN; HYDROCORTISONE; NIFEDIPINE;

ADRENAL CORTEX ATROPHY; ADRENAL CORTEX TUMOR; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE PRODUCING ADRENOCORTICAL MICROADENOMA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTISOL PRODUCING ADRENAL MACROADENOMA; CUSHINGOID SYNDROME; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LAPAROSCOPIC SURGERY; PLASMA RENIN ACTIVITY; PREOPERATIVE EVALUATION; TREATMENT OUTCOME; URINARY EXCRETION;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ALDOSTERONE; CUSHING SYNDROME; FEMALE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPERTENSION; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78651405002     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.35     Document Type: Article

References (40)

1. Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008; 19: 88-90.
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al. Case detection, diag-nosis, and treatment of patients with primary aldo-steronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281.
3. Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A et al. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal ve-nous sampling. Hypertens Res 2007; 30: 1083-1095.
4. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T. Unique cases of unilateral hyperaldoster-onemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 2002; 51: 350-355.
5. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic inJapan. Hypertens Res 2004; 27: 193-202.
6. Weiss LM. Comparative histologic study of 43 metas-tasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984; 8: 163-169.
7. Weiss LM, Medeiros LJ, Vickery Jr AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989; 13: 202-206.
8. Sasano H. The adrenal cortex. In: Stefaneanu L, Sasano H, Kovacs K (eds). Molecular and Cellular Endocrine Pathology. Arnold: London, 2000, pp 221-252.
9. Honda T, Nakamura T, Saito Y, Ohyama Y, Sumino H, Kurabayashi M. Combined primary aldosteronism and preclinical Cushing's syndrome: an unusual case presentation of adrenal adenoma. Hypertens Res 2001; 24: 723-726.
10. Makino S, Oda S, Saka T, Yasukawa M, Komatsu F, Sasano H. A case of aldosterone-producing adrenocor-tical adenoma associated with preclinical Cushing's syndrome and hypersecretion of parathyroid hormone. Endocr J 2001; 48: 103-111.
11. Sugawara A, Takeuchi K, Suzuki T, Itoi K, Sasano H, Ito S. A case of aldosterone-producing adrenocortical adenoma associated with a probable post-operative adrenal crisis: histopathological analyses of the adre-nal gland. Hypertens Res 2003; 26: 663-668.
12. Suzuki J, Otsuka F, Inagaki K, Otani H, Miyoshi T, Terasaka T et al. Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion. Hypertens Res 2007; 30: 367-373.
13. Tsunoda K, Abe K, Yamada M, Kato T, Yaoita H, Taguma Y et al. A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushing's syndrome. Hypertens Res 2008; 31: 1669-1675.
14. Rossi E, Foroni M, Regolisti G, Perazzoli F, Negro A, Santi R et al. Combined Conn's syndrome and subclinical hypercortisolism from an adrenal adenoma associated with homolateral renal carcinoma. Am J Hypertens 2008; 21: 1269-1272.
15. Okura T, Miyoshi K, Watanabe S, Kurata M, Irita J, Manabe S et al. Coexistence of three distinct adrenal tumors in the same adrenal gland in a patient with primary aldosteronism and preclinical Cushing's syndrome. Clin Exp Nephrol 2006; 10: 127-130.
16. Saito T, Ikoma A, Saito T, Tamemoto H, Suminaga Y, Yamada S et al. Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland. Endocr J 2007; 54: 287-293.
17. Oki K, Yamane K, Sakashita Y, Kamei N, Watanabe H, Toyota N et al. Primary aldosteronism and hypercorti-solism due to bilateral functioning adrenocortical adenomas. Clin Exp Nephrol 2008; 12: 382-387.
18. Onoda N, Ishikawa T, Nishio K, Tahara H, Inaba M, Wakasa K et al. Cushing's syndrome by left adrenocor-tical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: report of a case. Endocr J 2009; 56: 495-502.
19. Newton MA, Laragh JH. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism. J Clin Endocrinol Metab 1968; 28: 1006-1013.
20. Slaton Jr PE, Schambelan M, Biglieri EG. Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma. J Clin Endo-crinol Metab 1969; 29: 239-250.
21. Cain JP, Tuck ML, Williams GH, Dluhy RG, Rosenoff SH. The regulation of aldosterone secretion in primary aldosteronism. Am J Med 1972; 53: 627-637.
22. Ganguly A, Melada GA, Luetscher JA, Dowdy AJ. Control of plasma aldosterone in primary aldosteron-ism: distinction between adenoma and hyperplasia. J Clin Endocrinol Metab 1973; 37: 765-775.
23. Kem DC, Weinberger MH, Higgins JR, Kramer NJ, Gomez-Sanchez C, Holland OB. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocri-nol Metab 1978; 46: 552-560.
24. Stowasser M, Klemm SA, Tunny TJ, Gordon RD. Plasma aldosterone response to ACTH in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol 1995; 22: 460-462.
25. Kem DC, Weinberger MH, Gomez-Sanchez C, Kramer NJ, Lerman R, Furuyama S et al. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Invest 1973; 52: 2272-2277.
26. Vetter H, Berger M, Armbruster H, Siegenthaler W, Werning C, Vetter W. Episodic secretion of aldosterone in primary aldosteronism: relationship to cortisol. Clin Endocrinol (Oxf) 1974; 3: 41-48.
27. Schambelan M, Brust NL, Chang BC, Slater KL, Biglieri EG Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab 1976; 43: 115-131.
28. Kem DC, Weinberger MH, Gomez-Sanchez C, Higgins JR, Kramer NJ. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldoster-onism. J Lab Clin Med 1976; 88: 261-270.
29. Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos GP, Allolio B. Expression of adrenocortico-trophic hormone receptor mRNA in human adreno-cortical neoplasms: correlation with P450scc expression. Clin Endocrinol (Oxf) 1997; 46: 619-626.
30. Reincke M, Beuschlein F, Menig G, Hofmockel G, Arlt W, Lehmann R et al. Localization and expression of adrenocorticotropic hormone receptor mRNA in nor-mal and neoplastic human adrenal cortex. J Endocrinol 1998; 156: 415-423.
31. Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J Endocrinol 2007; 195: 39-48.
32. Zwermann O, Suttmann Y, Bidlingmaier M, Beus-chlein F, Reincke M. Screening for membrane hormone receptor expression in primary aldosteronism. Eur J Endocrinol 2009; 160: 443-451.
33. Allolio B, Reincke M. Adrenocorticotropin receptor and adrenal disorders. Horm Res 1997; 47: 273-278.
34. Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M. ACTH-receptor expression, regulation and role in adrenocortial tumor formation. Eur J Endocrinol 2001; 144: 199-206.
35. Mancini T, Kola B, Mantero F, Arnaldi G Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotro-pin. J Clin Endocrinol Metab 2003; 88: 1994-1998.
36. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idio-pathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 2006; 29: 883-889.
37. Nishizawa K, Nakamura E, Kobayashi T, Kamoto T, Terai A, Terachi T et al. Successful treatment of primary aldosteronism due to computed tomography-negative microadenoma. Int J Urol 2003; 10: 544-546.
38. Tamura Y, Adachi J, Chiba Y, Mori S, Takeda K, Kasuya Y et al. Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling. Intern Med 2008; 47: 37-42.
39. Myint KS, Watts M, Appleton DS, Lomas DJ, J Amieson N, Taylor KP et al. Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension. J Renin Angiotensin Aldosterone Syst 2008; 9: 103-106.
40. Sasano H. Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocr J 1994; 41: 471-482.